CEBRANOPADOL: A NOVEL FIRST-IN-CLASS ANALGESIC IN DEVELOPMENT FOR CHRONIC PAIN CONDITIONS - RESULTS FROM A HUMAN ABUSE POTENTIAL STUDY IN NON-DEPENDENT RECREATIONAL OPIOID USERS

¹Development, Grünenthal GmbH, Aachen, Germany,²Medical Affairs North America & Center for Abuse Prevention and Evaluation, Grünenthal USA Inc., Morristown, USA,³Data Sciences, Grünenthal GmbH, Aachen, Germany,⁴Clinical Pharmacology, Grünenthal GmbH, Aachen, Germany,⁵INC Research, Toronto, USA